35Pharma

Montreal, Canada Founded: 2021 • Age: 5 yrs Acquired By GSK
Designs and develops innovative biologics for unmet medical needs in healthcare.

About 35Pharma

35Pharma is a Healthcare company based in Montreal (Canada) founded in 2021, and was acquired by GSK in February 2026. It designs and develops innovative biologics for unmet medical needs in healthcare. It operates on a B2B model. 35Pharma offers products and services including HS135, HS235, and Ligand Traps. Its focus areas include Life Sciences, Therapeutics Development, Protein Engineering and Ligand Traps. Its legal entity is 35Pharma Inc.

Company details

35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.

  • Headquarters Montreal, Canada
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website 35pharma.com
  • Acquired by GSK (Feb 2026)
  • Legal Name 35Pharma Inc.
Key Metrics

Products & Services of 35Pharma

35Pharma offers a comprehensive portfolio of products and services, including HS135, HS235, and Ligand Traps.

HS135
Activin Inhibitor

Therapeutic for treating pulmonary hypertension and related diseases

HS235
Activin Inhibitor

Therapeutic for cardiometabolic disease and obesity management

Ligand Traps
Biologic Development

Protein-based traps neutralizing pathological factors in diseases

Investors in 35Pharma

35Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GSK.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Developer of pharmaceuticals and vaccines for various therapeutic areas
1715gsk.comBrentford, United Kingdom
Premium access

Investor details for 35Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of 35Pharma

13 people are tracked at 35Pharma (10 in leadership, 3 in team).

NameRoleGroup
George Georges
Chief Medical OfficerLeadership
Julie Bédard
Senior Director, Clinical OperationsLeadership
Ilia A. Tikhomirov
Chief Executive OfficerLeadership
Thomas Loisel
Vice President Of ManufacturingLeadership
Thomas P. Loisel
Vice President Of ManufacturingLeadership
Monique Champagne
Vice President Clinical OperationsLeadership
Julia Schoelermann
Vice President Corporate DevelopmentLeadership
Maureen O’connor
Chief Scientific OfficerLeadership
Gilles Tremblay
Vice President Preclinical DevelopmentLeadership
Dan Chiche
Chief Medical OfficerLeadership
Sarya Aziz
Program Manager, Clinical & Regulatory OperationsTeam
Claire Viallard
Scientist, Translational ScienceTeam
Guillaume Lemieux
Associate Project ManagerTeam
Premium access

Complete people profiles for 35Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of 35Pharma

2 dated milestones of 35Pharma across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded 35Pharma is founded.
  2. Exit Acquired by GSK.

Web traffic of 35Pharma

Websites that share an audience with 35Pharma (35pharma.com).

Similar websites

Websites whose visitors overlap most with 35Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
innodemneurosciences.com
82%
1.4KView details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about 35Pharma

35Pharma was founded in 2021.

35Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

35Pharma is a biopharmaceutical company that designs and develops biologics targeting the TGF-beta superfamily for diseases like pulmonary hypertension and obesity. It combines protein engineering expertise with rigorous manufacturing processes to create potent ligand traps. Based in Montreal, Canada, the company advances therapies through clinical trials and partnerships, aiming to improve patient outcomes with a focus on urgent medical needs.

35Pharma offers HS135, HS235, and Ligand Traps.

35Pharma has 1 investor. Key investors include GSK.

35Pharma operates through 35Pharma Inc..

Yes. 35Pharma was acquired by GSK in February 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available